Although various studies illustrate tumor promoting and prometastatic effects of CXCR4 [71], [72], its expression also plays a pivotal role in haematopoiesis [73] and has recently been reported as a good prognostic indicator in multiple myeloma [74]. Here, CXCR4 is linked to plasma cell myeloma.